HEALTH, FUNCTIONAL STATUS, AND EMPLOYMENT OF ADULT SURVIVORS OF BONE-MARROW TRANSPLANTATION

被引:134
作者
WINGARD, JR [1 ]
CURBOW, B [1 ]
BAKER, F [1 ]
PIANTADOSI, S [1 ]
机构
[1] JOHNS HOPKINS UNIV, SCH HYG & PUBL HLTH, DEPT ENVIRONM HLTH SCI, DIV OCCUPAT HLTH, BALTIMORE, MD 21218 USA
关键词
D O I
10.7326/0003-4819-114-2-113
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To determine the health, functional ability, and employment status of adults who survive bone marrow transplantation. Design: Inception cohort study. Setting: Patients who received transplants at a single referral-based center. Patients: Adults of 18 years of age or older who had received bone marrow transplants at least 6 months previously and who were not in a life-threatening relapse were surveyed a mean of 47 months after transplant (median, 37 months; range, 6 to 149 months). Of 171 eligible patients, 157 were contacted and 135 (86%) responded. Measurements and Main Results: Patients completed a mailed survey. Medical records were also reviewed. Most patients (93%) reported they could do normal activities with minor or no physical problems (Karnofsky scores, greater-than-or-equal-to 80%). Global health was described as good to excellent by 67% of subjects. Most perceived social activities (80%) or physical functional abilities (67%) to be unimpaired or only slightly affected. Moderate or severe pain was uncommon (13%). Sixty-five percent had returned to full- or part-time employment, and one third of those who were not employed were attending school. Job discrimination and problems in obtaining insurance were reported by 23% and 39%, respectively. Among those who had been employed before illness, loss of employment was associated with lower social functioning, chronic graft-versus-host disease, greater job discrimination, and female gender using multivariate logistic regression. Conclusions: Most subjects surviving bone marrow transplant reported good to excellent health and functional ability. Three fourths were employed or enrolled in school. These outcomes are comparable to outcomes in survivors of cancer who received less intensive treatments.
引用
收藏
页码:113 / 118
页数:6
相关论文
共 40 条
[1]  
ANDRYKOWSKI MA, 1989, BONE MARROW TRANSPL, V4, P75
[2]  
ANDRYKOWSKI MA, 1989, BONE MARROW TRANSPL, V4, P505
[3]  
APPELBAUM FR, 1988, BLOOD, V72, P179
[4]   BONE-MARROW TRANSPLANTATION OR CHEMOTHERAPY AFTER REMISSION INDUCTION FOR ADULTS WITH ACUTE NONLYMPHOBLASTIC LEUKEMIA - A PROSPECTIVE COMPARISON [J].
APPELBAUM, FR ;
DAHLBERG, S ;
THOMAS, ED ;
BUCKNER, CD ;
CHEEVER, MA ;
CLIFT, RA ;
CROWLEY, J ;
DEEG, HJ ;
FEFER, A ;
GREENBERG, PD ;
KADIN, M ;
SMITH, W ;
STEWART, P ;
SULLIVAN, K ;
STORB, R ;
WEIDEN, P .
ANNALS OF INTERNAL MEDICINE, 1984, 101 (05) :581-588
[5]  
ARMITAGE P, 1987, STATISTICAL METHODS
[6]  
BAKER F, 1990, IN PRESS SOC SCI MED
[7]   COMPARISON BETWEEN BONE-MARROW TRANSPLANTATION AND ANTITHYMOCYTE GLOBULIN IN TREATMENT OF YOUNG-PATIENTS WITH SEVERE APLASTIC-ANEMIA [J].
BAYEVER, E ;
CHAMPLIN, R ;
HO, W ;
LENARSKY, C ;
STORCH, S ;
LADISCH, S ;
GALE, RP ;
FEIG, SA .
JOURNAL OF PEDIATRICS, 1984, 105 (06) :920-925
[8]  
BORTIN MM, 1988, NAT IMMUN CELL GROW, V7, P334
[9]  
BRAINE HG, 1987, BONE MARROW TRANSPL, V2, P7
[10]   TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA - A PROSPECTIVE CONTROLLED TRIAL OF BONE-MARROW TRANSPLANTATION VERSUS CONSOLIDATION CHEMOTHERAPY [J].
CHAMPLIN, RE ;
HO, WG ;
GALE, RP ;
WINSTON, D ;
SELCH, M ;
MITSUYASU, R ;
LENARSKY, C ;
ELASHOFF, R ;
ZIGHELBOIM, J ;
FEIG, SA .
ANNALS OF INTERNAL MEDICINE, 1985, 102 (03) :285-291